baber/WOPTO huggingface dataset:
Patent JP-2000511710-A (JP)
Title: 半導体ウェーハのプロセス装置
IPC: H01L21/205
Filed: 1998-01-27
Abstract: (57)【要約】
分配用システムへの連結を除いて完全に閉鎖された少なくも１個の処理室を備えた半導体ウェーハの処理装置である。前記少なくも１個の処理室内に、好ましくは２個のリアクタ、及び選択的にボート内に配置されたウェーハに同じ処理作業を受けさせるための共通の供給／取出し用システムが置かれる。
Patent JP-2001514674-A (JP)
Title: アルキレンイミン／有機バリヤコーティング製造方法とその応用
IPC: C08F290/14
Filed: 1998-01-16
Abstract: (57)【要約】
本発明は、ガスおよび香気バリア性を基材に提供する組成物を教示し、その組成物はエチレン系不飽和酸とポリアミンを混合することにより得られ、該ポリアミンは随意に内部で反応する架橋剤を有し、該ポリアミンはA、BまたはCユニットを４個以上有するが、ここで、Ａは-R 2 -N(R 1 ) 2 ユニット、Ｂは-R 1 -N(R 2 -) 2 ユニット、Ｃは(-R 2 ) 3 N-ユニットであり、上式で、Ｒ 1 は、独立に、水素、アルキル、置換アルキル、アリール、置換アリール、アリールアルキルおよびアルキルアリールから選択され、Ｒ 2 は、独立に、炭素数が１から１８の直鎖または分岐したアルキレン基または置換されたアルキレン基、炭素数が６から１８のアリーレン基または置換されたアリーレン基からなる群より選択される。本組成物は基材に塗布され、その後随意にフリーラジカル反応を開始するよう処理される。本発明は、包装用途に用いられる広範囲の基材に塗布するコーティングとして用いられる。
Patent JP-2002503362-A (JP)
IPC: G07C9/00
Filed: 1998-02-17
Abstract: In the past, user authorization based on biometric information was conducted by correlating a single instance of biometric information against a template. By using this method, a percentage of the population is difficult to authenticate. Further, due to skin damage and injuries, sometimes biometric information is not suited to identification. A sore throat affecting voice information and scraped finger tips affecting fingerprint information are two examples of common problems with authorization in dependence upon biometric information. A method of authenticating a user in dependence upon biometric input information is disclosed. The method allows a user to select biometric information sources and a number of repetitions for each source in order to customize the process of biometric user authentication.
Patent JP-2000509488-A (JP)
Title: バイオセンサー
IPC: G01N27/12
Filed: 1997-04-17
Abstract: (57)【要約】
装置及び方法は、センサーの生物学的薬剤が相互作用をする成分と接触することにより生じるバイオセンサーのキャパシタンスとコンダクタンスとの少なくともいずれか一方の変動を決定するために、提供される。
Patent JP-2000510007-A (JP)
Title: 可撓性のある管のための締め付け閉塞装置
IPC: A61M5/168
Filed: 1997-04-30
Abstract: (57)【要約】
本発明は、締め付けることによって閉鎖するための閉鎖装置、特に医学の分野で使用される可撓性のある管又はホースに関する。本質的に、この装置には、円形のオリフィス（７６）によって延ばされた円形弧状のスロット（７０）が設けられている。この閉鎖部材（６２）が、スロット（７０）の半径に等しい半径（Ｒ）の円の点Ｏ回りに回転されることができる。
Patent JP-2000505478-A (JP)
IPC: A61K38/21
Filed: 1997-05-05
Abstract: A method for stimulating host defense mechanisms in a mammal via administering to the mammal a therapeutically effective amount of an interferon via oromucosal contact. The amount of interferon administered is less than an amount which induces a pathological response when administered parenterally.
Patent JP-2000511518-A (JP)
Title: 時間生物学的薬剤としてのベンゾフランおよびベンゾピラン
IPC: A61K31/34
Filed: 1997-05-13
Abstract: (57)【要約】
式(I)
 （上記式中、Ｒ 1 およびＲ 2 は、同一でもまたは異なっていてもよく、Ｈ、Ｃ 1   〜6 アルキル、Ｃ 3   〜7 シクロアルキル、またはアリールであり、Ｒ 3 およびＲ 4 は、同一でもまたは異なっていてもよく、Ｈ、ハロゲン、Ｃ 1   〜6 アルキル、または置換アリールであり、Ｒ 5 は、ＨまたはＣ 1   〜6 アルキルであり、またはｎは、整数０、１または２であり、ｍは、整数１、２、３または４であり、点線は、追加の結合の存在または非存在を示す）の化合物、およびその薬学上許容可能な溶媒和物。
Patent JP-2001526620-A (JP)
Title: リチウム化した金属酸化物
IPC: H01M4/131
Filed: 1998-03-09
Abstract: (57)【要約】
一般式：Ｌｉ ay Ｍ bx Ｍ’ b(1-x) Ｏ bz 、ここでａは１又は２、ｂは１又は２、０≦ｘ≦１、０≦ｙ≦１、１．８≦ｚ≦２．２、ＭとＭ’は多価金属、で示されるリチウム化した多価金属酸化物、該リチウム化した金属酸化物の合成法、及び該リチウム化した金属酸化物を活性物質として用いた少なくとも１の電極をもつ再充電性リチウム系バッテリー、この方法は少なくとも１のリチウムカルボキシレート又はリチウムアルコキシド塩、少なくとも１の金属カルボキシレート塩及びアルコール溶媒を合体しこれを熱の存在下に反応させ、反応混合物を乾燥して揮発性副生物と溶媒を除き、次いで熱処理することからなる。
Patent JP-2001521499-A (JP)
Title: 改善された口腔感覚を有する口腔用組成物
IPC: A23L19/18
Filed: 1998-03-19
Abstract: (57)【要約】
この発明は、脂肪質、クリーム質、落ち着き、満足感および十分な口あたりについて感覚受容特性の高い、そしてグリセロール骨格のＯＨ - 基の位置に結合した置換基Ｒ 1 、Ｒ 2 およびＲ 3 を有するアシルグリセロール化合物を含む口腔用組成物に関する。置換基Ｒ 1 Ｒ 2 は、それぞれ１６〜２２個の炭素原子を有する共役多不飽和脂肪酸から選択し、そしてＲ 3 はＲ 1 、ＯＨ、ＰＯ 3 ＨＲ 4 およびＣ6〜Ｃ12カルボン酸からなる群から選択し、ここでＲ 4 はＯＨ、コリン、イノシトール、セリン、エタノールアミンからなる群から選択する。この発明の口腔用組成物には遊離共役多不飽和脂肪酸がほとんど含まれていない。
Patent JP-2001518093-A (JP)
Title: 細胞壁の生合成を阻害するウンデカプレノール・キナーゼ阻害剤の使用
IPC: A61P31/04
Filed: 1998-03-24
Abstract: (57)【要約】
本発明は、細菌の増殖を阻害する材料および方法に関する。特に、細胞壁合成を妨害することによって細菌を制御する化合物を提供する。
Patent JP-2002511960-A (JP)
Title: ドータボードへのキャリアカードインターフェース
IPC: H04Q1/02
Filed: 1998-04-09
Abstract: (57)【要約】
ドータボードとのインターフェースは、キャリアカードと、キャリアカード上に設けられ、ドータボードをキャリアカードに結合するよう動作可能なボードインターフェースコネクタと、キャリアカードとドータボードとの間を結合する制御メッセージバスとを含む。さらにインターフェースは、キャリアカード上に設けられたオンボードコントローラを含む。オンボードコントローラは、制御メッセージバス上を移送される制御メッセージを受信することによって、および伝送することによって、ドータボードと通信する。インターフェースはまた、キャリアカードとドータボードとの間でデータを移送するよう適用されるデータバスと、データバスインターフェースとを含む。データバスインターフェースは、オンボードコントローラの制御により、データバスを介してドータボードに複数のチャネルの電気通信データを移送するよう動作可能なオンボードコントローラに結合されている。
Patent JP-2001523190-A (JP)
Title: 海洋アンカー
IPC: B63B21/26
Filed: 1998-04-30
Abstract: (57)【要約】
海底に貫入する海洋アンカー装置（１、３３）は低摩擦面（８、１２、１３、１４）の形状のその外面の少なくとも一部を有する。この装置は（ａ）索引埋設アンカー（１）で構成するか、（ｂ）代案として直接埋設アンカー（１Ａ）で構成することができる。この装置の外面に付着した低摩擦コーティングにより、又は外面に塗布したコーティングにより、低摩擦面を形成することができる。土壌の摩擦作用によって失われた潤滑剤を補給するため、潤滑剤供給装置（１６、１９）を設けることができる。
Patent JP-2001527734-A (JP)
Title: 伝送システムにおけるデータの予測
IPC: H03M7/40
Filed: 1999-02-22
Abstract: (57)【要約】
伝送媒体を通じてディジタル情報信号を送信するための送信器が開示される。ディジタル情報信号は符号化されたデータ及び係数データへ圧縮される。係数データは予測され、予測信号を生成する。係数データ及び予測信号はデータ信号へ組み合わされる。符号化されたデータ及びデータ信号は共に伝送媒体を通じて伝送される。
Patent JP-2002503388-A (JP)
Title: 口金付き電球
IPC: H01K1/46
Filed: 1999-03-22
Abstract: (57)【要約】
電球は、ランプ容器（１）及びキャップ（１０）を具え、キャップは、ハウジング（１１）と、連結手段（１７）を有する中間スプリング部（１５）とを有する。キャップ（１０）に、コンタタト手段（１４）及び参照手段（９）を設ける。スプリング部（１５）は、永続的な押圧力によって電球を支持部（３０）に配置する。電球は、コンパクトであり、簡単に組み立てられ、かつ、前方、後方及びプレートに装着して用いることができ、好適にはアダプタ（２５）と組み合わせる。
Patent NZ-204964-A (NZ)
Title: Heterocyclic-substituted 1,4-dihydropyridine derivatives and pharmaceutical compositions
Inventor: CAMPBELL S F
IPC: A61K31/445
Filed: 1983-07-20
Abstract: 1,4 Dihydropyridine derivatives of the formula:- 
<CHEM>
 wherein R is aryl heteroaryl; R<1> and R<2> are eacn independently C1-C4 alkyl or 2-methoxyethyl; Y is -(CH2)n-, -CH2CH(CH3)- or -CH2C(CH3)2-; n is 1 to 3; and X is a 5 or 6 membered nitrogen containing aromatic heterocyclic ring which may optionally be substituted by one or more C1-C4 alkyl, phenyl, benzyl, CN, -N(R<3>)2, (CH2)mCO2H, (CH2)mCO2(C1-C4 alkyl) or (CH2)mCON(R<3>)2 group wherein each R<3> is independently H or C1-C4 alkyl and m is 0 or 1; and their pharmaceutically acceptable acid addition salts, and pharmaceutical preparation containing such compounds, have utility as anti-ischaemic and antihyperensive agents.
Patent NZ-223020-A (NZ)
Title: Thickened bleach composition
Inventor: MOTSON HAROLD RUSSELL
IPC: C11D3/395
Filed: 1987-12-21
Abstract: Thickened bleaches of enhanced viscosity consist of water, alkali metal hypochlorite and a thickening agent consisting of a mixture of straight chain C14 amine oxide with a mixture comprising branched chain and straight chain C15 amine oxides.
Patent NZ-235101-A (NZ)
Title: A method of treating premature ejaculation using setraline
Inventor: BICK PETER A
IPC: A61P13/02
Filed: 1990-08-30
Abstract: A method of treating premature ejaculation comprising administering to a human in need of such treatment an amount of the compound (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthal enamine, also known by the generic name sertraline, or a pharmaceutically acceptable salt thereof, effective in delaying ejaculation.
Patent NZ-238269-A (NZ)
Title: Regulating transmission power level in mobile digital telephony
Inventor: LARSSON STIG MARTIN
IPC: H04B1/40
Filed: 1991-05-27
Abstract: The present invention relates to a method of regulating or adjusting the transmission power when transmitting signals between a mobile station and a base station in a digital mobile telephony system. The output power is regulated with the intention of constantly maintaining the transmission power at an optimum level, by which is meant that the transmission power is as low as possible such as to prevent unnecessary disturbance of neighbouring channels transmitting information on the same frequency, but sufficiently high for the transmitted information to be interpreted in the receiver. According to the inventive method, the measurement values of signal strength and signal-transmission quality are collected (1). The mean values of the signal strength and transmission quality (2) are calculated on the basis of the collected measurement values. With the aid of the calculated mean values, there is calculated an anticipated value of signal strength (Z_SS) and transmission quality (Z_QQ) at the next time-point t1, provided that the transmission power is maintained unchanged in relation to the transmission power at the present or instant time-point (t0). Finally, the transmission power (MS_PWR) at the next time-point (t1) is regulated on the basis of these anticipated values (Z_SS, Z_QQ). The transmission power (MS_PWR) is increased when the anticipated transmission quality is poorer than the desired quality and is increased when the anticipated quality is higher than the highest permitted quality or when the anticipated signal strength is greater than the maximum permitted value. The transmission power is otherwise maintained unchanged. <IMAGE>
Patent NZ-262170-A (NZ)
Title: Trisubstituted phenyl derivatives, preparation and pharmaceutical compositions thereof
Inventor: WARRELLOW GRAHAM JOHN
IPC: A01N43/40
Filed: 1994-03-09
Abstract: Compounds of general formula (1) are described wherein Y is a halogen atom or a group -OR1, where R1 is an optionally substituted alkyl group; X is -O-, -S- or -N(R7)-, where R7 is a hydrogen atom or an alkyl group; R2 is an optionally substituted cycloalkyl or cycloalkenyl group; R3 and R4, which may be the same or different, is each a hydrogen atom or an alkyl, -CO2R8 (where R8 is a hydrogen atom or an alkyl, aryl, or aralkyl group), -CONR9R10 (where R9 and R10 which may be the same or different is each a hydrogen atom or an alkyl, aryl or aralkyl group), -CSNR9R10, -CN, -CH2CN group; Z is -(CH2)n- (where n is zero or an integer 1, 2 or 3; R5 is an optionally substituted monocyclic or bicyclic aryl group optionally containing one or more heteroatoms selected from oxygen, sulphur or nitrogen atoms; R6 is a hydrogen atom or a hydroxyl group; and the salts, solvates, hydrates, prodrugs and N-oxides thereof. Compounds according to the invention are potent and selective phosphodiesterase type IV inhibitors and are useful in the prophylaxis and treatment of diseases such as asthma where an unwanted inflammatory response or muscular spasm is present.
Patent NZ-274481-A (NZ)
Title: Isolating a nonsense suppressor encoding lactic acid bacterium, cultures thereof and use
Inventor: DICKELY FRANCOISE
IPC: C12N15/74
Filed: 1994-10-07
Abstract: Useful mutants of lactic acid bacteria or plasmids capable of replicating in lactic acid bacteria, comprising nonsense mutation suppressor-encoding genes, the use of such suppressor genes for confining a replicon to a specific lactic acid bacterium or to a lactic acid bacterium growing in a particular environment and for controlling the number of lactic acid bacterial cells in a particular environment.
Patent NZ-277548-A (NZ)
Title: Controlled-release medicament; column composed of inner layer prepared from nondisintegratable biocompatible material containing a water-soluble drug and an outer layer of water-impermeable biocompatible material
Inventor: FUKJIOKA KEIJI
IPC: A61K9/22
Filed: 1994-12-26
Abstract: A drug formulation for producing sustained therapeutic efficacy, which releases water-soluble drug intracorporeally over a prolonged period of time at a substantially constant rate wherein said drug formulation comprises   (a) a nondisintegrating inner layer comprised of a biocompatible material that contains uniformly dispersed water-soluble drug; and (b) an outer layer comprised of a biocompatible material that surrounds the circumference of the said inner layer, is impermeable to water, and is capable of controlling the swelling of the inner layer; wherein the ratio of the axial length of the drug formulation to the cross-secitonal diameter of the inner layer is one or more and one or both ends of the inner layer are open so as to come into direct contact with the external environment.
Patent NZ-278668-A (NZ)
Title: Liquid to gel, ophthalmic sustained release delivery system
Inventor: YEN SHAU-FONG
IPC: A61K47/36
Filed: 1995-02-09
Abstract: Disclosed is a sustained release liquid aqueous ophthalmic delivery system and a method of providing a slow and sustained release of ophthalmic treating agents to the eye of a mammal which comprises administering to the eye of a said mammal an effective amount of a homogeneous liquid aqueous ophthalmic pharmaceutical composition, of pH between about 3.0 and about 6.2, which is adminstrable in drop form and which comprises an ophthalmically effective concentration of a said ophthalmic treating agent and about 0.05% to about 10% by weight of the polymer chitosan; said polymer consisting essentially of (A) monomeric  beta (1->4)-D-glucosamine linked units and of (B) monomeric  beta (1->4)-D-glucosamine linked units which are scattered randomly in the molecule of the polymer, the numerical proportions of A and B being from about 60 to about 99% of A and about 1 to about 40% of B, the viscosity rating being from about 3 to about 3000 cps; in which method, upon contact with the higher pH of the ocular fluid, said liquid formulation is converted to a stiff gel from which the ophthalmic treating agent is slowly released over a prolonged period of time.
Patent NZ-283741-A (NZ)
Title: Insecticide/fertilizer mixtures in small solid shaped forms containing stable mixtures of nicotinergic acetylcholine receptors of insects
Inventor: SCHUTTE MANFRED-HEINRICH
IPC: C05G3/60
Filed: 1995-04-03
Abstract: PCT No. PCT/EP95/01222 Sec. 371 Date Oct. 7, 1996 Sec. 102(e) Date Oct. 7, 1996 PCT Filed Apr. 3, 1995 PCT Pub. No. WO95/28370 PCT Pub. Date Oct. 26, 1995The present invention relates to insecticidal fertilizer mixtures comprising a fertilizer component and an agonist or antagonist of the nicotinergic acetylcholine receptors of insects.
Patent NZ-305067-A (NZ)
Title: Use of amidoamines in ophthalmic compositions
Inventor: DASSANAYAKE NISSANKE L
IPC: A61K31/164
Filed: 1996-02-26
Abstract: The use of certain amidoamines to disinfect contact lenses and preserve ophthalmic compositions is described, Ophthalmic compositions containing these compounds as disinfecting agents or preservatives are also described, The amidoamines utilized in the present invention have potent antibacterial and antifungal activity, and are chemically compatible with inorganic ions and other materials utilized in ophthalmic compositions.
Patent NZ-323407-A (NZ)
Title: Movable covering device, particularly for swimming pools
Inventor: GIRERD MARC
IPC: E04H4/08
Filed: 1996-11-29
Abstract: PCT No. PCT/FR96/01891 Sec. 371 Date Jun. 1, 1998 Sec. 102(e) Date Jun. 1, 1998 PCT Filed Nov. 29, 1996 PCT Pub. No. WO97/20114 PCT Pub. Date Jun. 5, 1997A roof movable between a raised position in which it forms a shelter over a terrace and a lowered position in which it forms a cover over a swimming pool. The roof is mounted on pivotable pillars via hinges. One edge of the roof is supported in the raised position by a winch and cable device for moving the roof assembly between the two positions.
Patent NZ-334555-A (NZ)
Title: Polymeric immersion heating element with skeletal support
Inventor: ECKMAN CHARLES M
IPC: H05B1/02
Filed: 1997-11-20
Abstract: Electrical resistance heating element, hot water heaters containing such elements, and method of preparing such elements. The electrical resistance heating elements can be disposed through a wall of a tank for heating fluid, such as water. They include a skeletal support frame (70), having a first supporting surface (69), thereon. They also include a resistance wire (66) wound onto the first supporting surface (69) and preferably connected to at least a pair of terminal end portions. The support frame (70) and resistance wire (66) are then hermetically encapsulated and electrically insulated within a thermally conductive polymeric coating (64). The skeletal support frame (70) improves injection molding operations for encapsulating the resistance wire (66), and can include heat transfer fins (62) for improving thermal conductivity.
Patent NZ-337210-A (NZ)
Title: Regulating charging voltage or current in battery charger varying current or voltage in small steps
Inventor: KLANG JAMES K
IPC: H02J7/04
Filed: 1999-08-11
Abstract: A method of controllably charging a battery over a charging period comprises: a) connecting a charging voltage to the battery; b) applying a plurality of separate and distinct voltage steps in the charging voltage to the battery with the plurality of voltage steps being distributed over the charging period and each having a step magnitude significantly smaller than the charging voltage applied to the battery and c) for each of the plurality of voltage steps: i) detecting current changes induced by said each voltage step; ii) calculating a ratio from the detected current changes; and iii) varying the charging voltage according to the ratio. Also disclosed is an apparatus for charging a battery comprising: d) a variable DC power supply for providing adjustable charging voltage and charging current to the battery; e) a voltage controller for controlling the charging voltage of the variable DC power supply over a charging period and for applying a plurality of separate and distinct voltage steps distributed over the charging period to the battery for probing charging efficiency, each of the voltage steps having a step magnitude significantly smaller than the charging voltage applied to the battery; f) a current detector for detecting current changes in response to said each voltage step and g) an analyzer for determining a ratio from the detected current changes for said each voltage step with the voltage controller being coupled to the analyzer for varying the charging voltage according to the ratio for said each voltage step.
Patent NZ-337670-A (NZ)
Title: Ultrasound receiver assembly for presentation board digitiser, two receivers one above the other
Inventor: SHENHOLTZ GIDEON
IPC: G01S11/14
Filed: 1998-02-25
Abstract: An ultrasound receiver assembly for a presentation board digitiser includes two ultrasound receivers 32, 36.  One receiver 32 is adjacent to the board 30, while the other is displaced from the other in a direction perpendicular to the board surface.  The two receivers are connected so as to generate a total output signal corresponding to the instantaneous sum of the ultrasound signals received by receivers 32, 36 such that the receiver is most sensitive to ultrasound signals coming from a plane substantially adjacent to the presentation board.
Patent NZ-507576-A (NZ)
Title: Composite superconducting tapes
Inventor: ZHAO RUPENG
IPC: H01B12/02
Filed: 1999-03-18
Abstract: A composite superconducting tape (1) is made up of at least one constituent superconducting tape (2) (preferably a multiplicity of stacked and bonded such tapes) and at least one outer layer of metal tape (3) overlying and bonded to one of the exposed major faces; if there are two such metal tapes (3) and (4) they differ in strength.
Patent NZ-508268-A (NZ)
Title: Bicyclic pyrimidines and bicyclic 3,4- dihydropyrimidines as inhibitors of cellular proliferation
Inventor: DOBRUSIN ELLEN MYRA
IPC: C07D471/04
Filed: 1999-05-10
Abstract: Compounds of formula (I) are described, wherein: W is NH, S, SO, or SO2, X is O or S, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated by the inhibition of a non-receptor tyrosine kinase.
Patent NZ-510998-A (NZ)
Title: Triazine based anitcoccidial agents for treating protozoal infections
Inventor: MACLIN ROBERT
IPC: A61K31/5685
Filed: 1999-10-08
Abstract: A composition that has been specially adapted for parenteral administration, e.g., intranasal, intramuscular, subcutaneous, transdermal or intraveneous administration, wherein the composition is comprised of at least one anti-protozoal drug in a therapeutically effective amount for the treatment or prevention of protozoan infections in man and in animals. In one embodiment, the anti-protozoal drug is a triazine-based anticoccidial agent, e.g., a triazinedione or triazinetrione such as diclazuril, toltrazuril, sulfonotoltrazuril or water-soluble sodium salts thereof. In a presently preferred embodiment, the triazine-based anticoccidial agent is sulfonototrazuril. Methods of treatment of protozoal infections in man and animals are also provided.
Patent NZ-511138-A (NZ)
Title: Seat with two separate locking members to lock back in respective upright and lowered positions
Inventor: LEWIS GORDON
IPC: A47C17/04
Filed: 2001-04-17
Abstract: In order to cope with large loads when the seat is used in a vehicle the seat is provided with two separate devices 25,26 which respectively lock the seat in the upright and lowered (reclined) positions.
Patent NZ-513884-A (NZ)
Title: Packaging method and apparatus
Inventor: YAMAY YEHUDA
IPC: B65B31/02
Filed: 2000-02-23
Abstract: A method for packaging a product in a hermetically sealed container having a cup-shaped rigid or semi-rigid body with a rim fitted with a closure, the method comprising introducing the product into the cup-like shaped body (106). Forming an isolated space (204) with a gas inlet (134) and a gas outlet (112), the space defined between the body and a closure-forming member (200) adjacent to and with a clearance from the rim (107). Introducing a replacement gas through the inlet to replace at least a substantial portion of gas originally contained in the isolated space, and displacing at least one of the body or the closure-forming member towards the other of the two members to close the clearance and to attach the closure-forming member to the rim, and hermetically attaching the two to one another to form a gas-tight seal.
Patent NZ-514031-A (NZ)
Title: Packaging compressed stacks of a folded strip of material within a bag enclosure
Inventor: O'CONNOR LAWRENCE
IPC: B65D85/07
Filed: 2000-02-28
Abstract: A package (10) of a strip material includes a plurality of stacks of the strip side by side where each strip forms a stacked fan folded supply of the strip which is spliced to or arranged so that it can be subsequently spliced to a next adjacent strip for supply of a continuous strip from the package.  The side by side stacks are simultaneously built up from the bottom by moving a carriage (19) back and forth below a stationary bottom surface of the stacks with the strips supplied side by side through a slot in the carriage.  The stacks are supported side by side as they are built up by rigid side walls (55, 55A) of a chute or of a box into which the package is to be packaged for transportation.  The tails are supported or arranged so that they are ready for splicing when the package is completed and before transportation.  The packaging material can be an evacuated bag (54) or a rigid box.  Transfer of the completed stacks is effected simultaneously by a slip sheet arrangement or by moving one of the belts of the carriage as an ejection belt.
Patent NZ-517085-A (NZ)
Title: Process for recovering organic hydroxides from waste solutions
Inventor: MOULTON ROGER D
IPC: C25B3/00
Filed: 2000-08-08
Abstract: In one embodiment, the disclosed relates to a process for recovering an onium compound from waste solutions or synthetic solutions containing the onium compound and impurities including the steps: contacting the waste solution or synthetic solution with a metal ion scavenger to remove metal ion impurities, wherein the metal ion scavenger comprises at least one of a chelating compound, a nanoporous material, and a MACS material; charging the waste solution or synthetic solution to an electrochemical cell (10) containing at least two compartments (14, 15), a cathode (12), an anode (11) and a divider (D) and passing a current through the cell whereby the onium compound is regenerated or produced; and recovering the onium compound from the cell.
Patent NZ-525487-A (NZ)
Title: Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders
Inventor: GUSTAFSSON DAVID
IPC: C07D205/04
Filed: 2000-11-09
Abstract: The use of melagatran, or a pharmaceutically-acceptable derivative thereof, for the manufacture of a medicament for the treatment of an ischemic disorder in a patient having, or at risk of, non-valvular atrial fibrillation. Also disclosed is a method of treating an ischemic disorder when the patient to be treated is a non-human animal.